Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nafamostat mesilate for COVID-19 pneumonia (Phase 2, open-label RCT)
KCT0005003Phase 2Not yet recruiting
- Sponsor
- Ministry of Science and ICT
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Nafabelltan in coronavirus pneumonia, sponsored by Ministry of Science and ICT. Planned start May 2020; status: not yet recruiting.
02
Drugs
Nafabelltan
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on KCT0005003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005003.